Amanda Owens brings over 10 years of leadership in biotech commercial strategy and operations, guiding companies through growth inflection points in go-to-market planning, external partnerships, and investor engagement. She has held senior roles at EditCo Bio, Synthego, Discovery Life Sciences, and in her own consulting advisory practice. At Landmark Bio, Amanda leads commercial strategy and external engagement, helping translate advanced cell and gene therapy manufacturing into accessible patient therapies.
She holds a Bachelor’s degree in Biology and Physical Anthropology and a Master’s degree in Anthropology from the University of Alabama, as well as an MBA from the University of Alabama in Huntsville.